ATTENTION
To contact Dr. Kelly Wilmas, please call our Mohs Specialty line directly at +3148786647 or by fax at +3146276900.
close
Kelly Wilmas, MD, FAAD
Board-Certified Dermatologist
Board-Certified Mohs Surgeon
Fellowship-Trained Mohs Surgeon
It is a privilege to provide care to patients affected by skin conditions, to establish meaningful connections with them, and to improve their overall well-being.
- Kelly Wilmas, MD, FAAD, FACMS
Education

Undergraduate Degree:

University of Texas at Austin, Austin, TX

Medical Degree:

University of Texas Medical School at Houston, Houston, TX

Internship:

University of Texas Health Science Center at Houston, Houston, TX

Dermatology Residency

University of Texas MD Anderson Cancer Center, Houston, TX

Micrographic Surgery and Dermatologic Oncology Fellowship

University of California San Francisco, San Francisco, CA

Certificates
American Board of Dermatology
Professional Memberships
American Academy of Dermatology
American Society for Dermatologic Surgery
Women’s Dermatologic Society
American Society for Laser Medicine & Surgery
American Contact Dermatitis Society
Publications

Wilmas K, Patel J, Silapunt S, Doan HQ, Migden MR. The use of a dehydrated complete human placental membrane allograft for Mohs surgical defects of the nose. Dermatologic Surgery, 2023 Feb 13. PMID: 36799879.

Chen O, Kim K, Steele C, Wilmas KM, Aboul-Fettouh N, Burns C, Doan HQ, Silapunt S, Migden MR. Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma. Cancers. 2022 Jul 30;14(15):3720. PMID: 35954384.

Burns C, Kubicki S, Nguyen QB, Aboul-Fettouh N, Wilmas KM, Chen O, Doan HQ, Silapunt S, Migden MR. Advances in Cutaneous Squamous Cell Carcinoma Management. Cancers. 2022 Jul 27;14(15):3653. PMID: 35954316

Wilmas KM, Aria AB, Landis LN, Chaitanya SK, Prieto VG, Duvic M. CD4/CD8 double-negative mycosis fungoides with large cell transformation and involvement of the lungs and leptomeninges. Dermatology Online Journal. 2022 Mar 15;28(2):4. PMID: 35670681.

McNally M, Patel A, Wilmas KM, Thomas V, Heberton M. Cutaneous Surgery Outcomes in Patients on Epidermal Growth Factor Receptor Inhibitors. Dermatologic Surgery. 2021 Nov 1; 47(11):1519-1521. PMID: 34417386.

Wilmas KM, Nguyen QB, Patel J, Silapunt S, Migden MR. Treatment of advanced cutaneous squamous cell carcinoma: Mohs surgery & cutaneous oncology perspective. Future Oncology. 2021 Dec; (35):4971-4982. PMID: 34608809.

Wilmas KM, Garner W, Ballo M, McGovern S, MacFarlane DF. The role of radiation therapy in the management of cutaneous malignancies. Part I: Diagnostic modalities and applications. Journal of the American Academy of Dermatology. 2021 Sep; 85(3):539-548. PMID: 34116097.

Wilmas KM, Garner W, Ballo M, McGovern S, MacFarlane DF. The role of radiation therapy in the management of cutaneous malignancies. Part II: When is radiation therapy indicated? Journal of the American Academy of Dermatology. 2021 Sep; 85(3):551-562. PMID: 34116100.

Kim E, Aria A, Wilmas K, Lewis D, Dabaja B, Nunez C, Torres-Cabala C, Duvic M. Small-to-medium pleomorphic CD4+ T-cell lymphoproliferative disorder in a pediatric patient successfully treated with low-dose radiation. Pediatric Dermatology. 2019 Jan;36(1):e23-e26. PMID: 30548331.

Aria A, Wilmas K, Kim E, Aung P, Duvic M. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar. Dermatology Online Journal. 2018 Sep;24(9). PMID: 30677830.

Wilmas K, Aria A, Torres-Cabala C, Lu H, Duvic M. Schnitzler’s syndrome in a patient with a family history of monoclonal gammopathy. Dermatology Online Journal. 2018 Jan;24(1). PMID: 29469761.

Jenkinson HA, Wilmas KM, Silapunt S. Sodium tetradecyl sulfate: A review of clinical uses. Dermatologic Surgery. 2017 Nov;43(11):1313-1320. PMID: 28430735.

*Age Restriction


For patients scheduling who are under 18 years of age (19 in Alabama) please make sure you have permission from your parent or legal guardian to schedule this appointment.  Your parent or legal guardian must accompany you on your initial visit and on certain subsequent visits to provide appropriate informed consent.